These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 5047309

  • 1. [Secondary effects of parenterally administered polymeric compounds (polyvinylpyridine-N-oxide)].
    Lushnikova GA, Dubovik BV, Shadurskii KS, Lushnikov EF.
    Farmakol Toksikol; 1972; 35(3):363-6. PubMed ID: 5047309
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Increased phagocytosis in the reticuloendothelial system due to polyvinylpyridine-N-oxide].
    Flemming K, Nothdurft W.
    Klin Wochenschr; 1968 Aug 15; 46(16):904-5. PubMed ID: 5727479
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of antineoplastic agents on the accumulation of collargol in cells of the reticuloendothelial system].
    Korol'chuk VP, Iushkov SF.
    Farmakol Toksikol; 1970 Aug 15; 33(6):707-11. PubMed ID: 4996581
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
    Bogdanskaia NI, Tolgskaia MS.
    Gig Sanit; 1973 Apr 15; 38(4):102-4. PubMed ID: 4731236
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Modification of the phagocytic activity of the hepatic RES by PVNO (polyvinylpyridine-N-oxide)].
    Leonhardt L.
    Nucl Med (Stuttg); 1970 Mar 30; 9(1):98-100. PubMed ID: 5505740
    [No Abstract] [Full Text] [Related]

  • 10. [Mechanism of protective action of polyvinylpyridine-N-oxide].
    Shnaĭdman IM.
    Gig Tr Prof Zabol; 1974 Jan 30; 18(1):19-23. PubMed ID: 4839818
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Polyvinylpyridine-N-oxide and experimental silicosis].
    Sklensky BS.
    Gig Tr Prof Zabol; 1969 Jun 30; 13(6):22-7. PubMed ID: 5799471
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Inhibition of experimental silicosis by subcutaneous administration of polyvinylpyridine-N-oxide].
    SCHLIPKOETER HW, BROCKHAUS A.
    Klin Wochenschr; 1961 Nov 15; 39():1182-9. PubMed ID: 14498575
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of polyvinyl pyridine-N-oxide (P204) on the cytopathogenic action of chrysotile asbestos in vivo and in vitro.
    Davis JM.
    Br J Exp Pathol; 1972 Dec 15; 53(6):652-8. PubMed ID: 4345811
    [Abstract] [Full Text] [Related]

  • 19. [Biochemical and biophysical reactions of rat lung tissue to quartz and corundum with and without PVN-oxide treatment].
    Grünspan M, Antweiler H.
    Inhaled Part; 1970 Dec 15; 1():373-8. PubMed ID: 4366179
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.